Search Within

Khedoudja Nafa

  1. "Early Drug Development Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (7)
  2. Department of Pathology and Laboratory Medicine (7)
  3. Early Drug Development Service (7)
  4. GSK Faculty (7)
  5. Human Oncology and Pathogenesis Program (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Marc Ladanyi (7)
  2. Ahmet Zehir (6)
  3. David Hyman (6)
  4. Maria Arcila (6)
  5. Ryma Benayed (6)
  6. Jose Baselga (5)

More People

Years
  1. 2021 (1)
  2. 2019 (2)
  3. 2017 (3)
  4. 2015 (1)
Publications
  1. Journal of Molecular Diagnostics (2)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. JAMA - Journal of the American Medical Association (1)
  5. Journal of Clinical Oncology (1)
  6. Nature Medicine (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Science, Inc. (2)
  3. American Medical Association (1)
  4. American Society of Clinical Oncology (1)
  5. Nature Publishing Group (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes
    Journal Article

    Chang, J. C.; Offin, M.; Falcon, C.; Brown, D.; Houck-Loomis, B. R.; Meng, F.; Rudneva, V. A.; Won, H. H.; Amir, S.; Montecalvo, J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Colorectal carcinomas containing hypermethylated MLH1 promoter and wild-type BRAF/KRAS are enriched for targetable kinase fusions
    Journal Article

    Cocco, E.; Benhamida, J.; Middha, S.; Zehir, A.; Mullaney, K.; Shia, J.; Yaeger, R.; Zhang, L.; Wong, D.; Villafania, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Next-generation assessment of human growth factor receptor 2 (ERBB2) amplification status: Clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay
    Journal Article

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Benayed, R.; Nafa, K.; Hechtman, J. F.; Janjigian, Y. Y.; Weigelt, B.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2017)

    Fulltext@MSK | Save
  • The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays
    Meeting Abstract

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Nafa, K.; Jour, G.; Razavi, P.; Hyman, D. M.; Baselga, J.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save